InvestorsHub Logo
icon url

jderaney

10/20/13 12:38 PM

#258 RE: kaisersosze #257

These guys are never always right or never always wrong. Just like the rest of us.

They say VNDA changed the endpoints of the study without FDA permission therefore the Advisory panel will recommend a No approval.

If you read the transcript of qtr 2 conference call when this question was asked, VNDA management said they changed the endpoints based on a recommendation from the FDA.

Do you believe them or management?
icon url

LasNubes

10/21/13 7:42 AM

#259 RE: kaisersosze #257

I stopped out at 9.80

Thinking about getting back in if it only reaches a bottom.

I may wait until after ADCOM result and ride it to PDUFA date, if ADCOM is favorable?

It's on high alert on my watch list along with MSTX

Good luck